As an employee at Bard I am here to say that it's not just USCI that's lagging it's Interventional Products as well. Over the last year we have seen a mass exodus of people leave this division including a couple of our most talented engineers, one of which went to a direct competitor (with the initials Microvasive). How are we expected to compete with the likes of BSX, USSC, J&J and Medtronic if we can't keep good people. We have very little to offer. It is unlikely that we are going to come out with any innovative products until we can find a way to attract talented, skilled people back to Bard. Back in the 80's Bard was the place to work, now it's a place to hang your hat. I hope management here and through out Bard get the message, competing is not about me-to products it's about spending money to keep the right resources in place to create and lead in the marketplace. As it has been said: lead, follow or get out of the way.